Coherus Biosciences Inc CHRS

NAS: CHRS | ISIN: US19249H1032   3/05/2024
2,270 USD (+4,61%)
(+4,61%)   3/05/2024

4 januari 2024 · INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi) · Persbericht

7 november 2023 · Thinking about buying stock in Applied Therapeutics, Coherus Biosciences, Tempest Therapeutics, Bluegreen Vacations Holding, or Adams Resources & Energy? · Persbericht

1 november 2023 · Thinking about buying stock in AERWINS Technologies, Arista Networks, Lucid Group, C3.ai, or Coherus Biosciences? · Persbericht

30 oktober 2023 · Thinking about buying stock in Coherus Biosciences, Vyne Therapeutics, Intuitive Machines, SoFi Technologies, or Cybin? · Persbericht

2 september 2023 · Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 · Persbericht

3 maart 2021 · Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma · Persbericht

25 februari 2021 · Coherus Management to Present at Upcoming Investor Conferences · Persbericht

24 februari 2021 · Coherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results · Persbericht

17 februari 2021 · Coherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for Review · Persbericht

2 februari 2021 · Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences · Persbericht

1 februari 2021 · Coherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi Biosciences’ PD-1, toripalimab, in United States and Canada · Persbericht

22 januari 2021 · Coherus BioSciences Announces New Employment Inducement Grants · Persbericht

7 januari 2021 · Coherus BioSciences Appoints Alan Mendelson and Mark Stolper to Board of Directors · Persbericht

5 januari 2021 · Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Mijn selecties